On April 13, 2023, Aimed Alliance sent a letter to the North Dakota Legislative Assembly urging the Assembly to swiftly…
In 2017, Texas passed a step-therapy law that placed guardrails on step-therapy policies to protect health care consumers. Step therapy,…
At the end of February 2023, Aimed Alliance sent a letter to the Food and Drug Administration (FDA) Office of…
On April 5, 2023, the Centers for Medicare and Medicaid Services (CMS) issued a final rule revising the regulations governing…
The federal government’s COVID-19 public health emergency (PHE) declaration will end on May 11, 2023. The drug poisoning PHE, first…
This session will focus on the emerging role of digital therapeutics (DTx) in the treatment of substance use disorders (SUDs),…
On March 20, 2023, Aimed Alliance released a new fact sheet titled “Alternative Funding Programs: The Cost Sharing Program That…
On February 27, Aimed Alliance released a new Know Your Rights brochure for patients with Rare Endocrine Disorders. An endocrine…
For many individuals it can feel overwhelming being diagnosed with a new rare or chronic condition. This can be especially true…
On February 13, 2023, the Drug Enforcement Administration (DEA) responded to an inquiry by a North Carolina attorney regarding the…